Allogene Therapeutics Reports Second Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports Second Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 2.10 -0.13 (5.83%)
Previous Close $2.23    52 Week High
Open $2.19    52 Week Low
Day High $2.21    P/E N/A 
Day Low $2.07    EPS
Volume 4,860,785